Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor - A clinical research center study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 10, 1996, Pages 3802-3806

  Rosenthal, Ira M ^a,c   Refetoff, Samuel ^a   Rich, Barry ^a   Barnes, Randall B ^a   Sunthornthepvarakul, Thongkum ^a   Parma, Jasmine ^b   Rosenfield, Robert L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GONADORELIN ANTIBODY; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; NAFARELIN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CASE REPORT; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HYPOPHYSIS GONAD SYSTEM; LEYDIG CELL; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MENSTRUAL CYCLE; OVARY FUNCTION; PRECOCIOUS PUBERTY; PRIORITY JOURNAL;

ADULT; ANDROGENS; CHILD, PRESCHOOL; DEXAMETHASONE; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GENOTYPE; HORMONES; HUMANS; LUTEINIZING HORMONE; MALE; MUTATION; NAFARELIN; PEDIGREE; PUBERTY, PRECOCIOUS; RECEPTORS, LH; TESTOSTERONE;

RAPHIA FRATER;

EID: 0029840021     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.10.3802     Document Type: Article

References (29)

1. Schedewie HK, Reiter EO, Beitins IZ, et al. 1981 Testicular Leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocrinol Metab. 52:271-278.
2. Rosenthal SM, Grumbach MM, Kaplan SL. 1983 Gonadotropin independent familial sexual precocity with premature Leydig and germinal cell maturation ("familial testotoxicosis"). Effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. J Clin Endocrinol Metab. 57:571-579.
3. Rabl W, Knorr D, Bidlingmaier F, Butenandt O, Mann K. 1986 Familial male precocious puberty in 3 generations. Acta Endocrinol (Copenh). 274(Suppl):2-3.
4. Kremer H, Mariman E, Otten BJ, et al. 1993 Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Gen. 2:1779-1783.
5. Shenker A, Laue L, Kosugi S, Merendino JJ, Minegishi T, Cutler Jr GB. 1993 A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature. 365:652-654.
6. Yano K, Hidaka A, Saji M, et al. 1994 A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases. J Clin Endocrinol Metab. 79:1818-1823.
7. Kawate N, Kletter GB, Wilson BE, Netzloff ML, Menon KMJ. 1995 Identification of the constitutively activating mutation of the luteinizing hormone receptor in a family with male limited gonadotropin independent precocious puberty (testotoxicosis). J Med Genet. 32:553-557.
8. Laue L, Chan W, Hsueh AJW, et al. 1995 Genetic heterogeneity of constitutively activating mutations of the hormone luteinizing hormone receptor in familial male-limiting precocious puberty. Proc Natl Acad Sci USA. 92:1906-1910.
9. Kosugi S, Van Dop C, Geffner ME, et al. Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum Mol Genet. 4:183-188.
10. Yano K, Saji M, Hidaka A, et al. 1995 A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. J Clin Endocrinol Metab. 80:1162-1168.
11. Latronico AC, Anasti J, Arnhold IJP, et al. 1995 A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab. 80:2490-2494.
12. Rabl W, Storm TM, Knorr D, Dorr HG, Senekowitsch R, Merendino Jr JJ, Shenker A. 1994 Familial male precocious puberty (FMPP): clinical and molecular genetic heterogeneity in 2 kindreds [Abstract]. Horm Res. 41:113.
13. Boepple P, Crowley WJ, Albanese C, Jameson J. Activating mutations of the LH receptor in sporadic male gonadotropin-independent precocious puberty [Abstract 494]. Proc of the 76th Annual Meeting of The Endocrine Society. 1994.
14. Ehrmann DA, Barnes RB, Rosenfield RL. 1995 Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev. 16:322-353.
15. Cuttler L, Rosenfield RL, Ehrmann DA, Burstein S, Cara JF, Levitsky LL. 1993 Maturation of gonadotropin and sex steroid responses to gonadotropin-releasing hormone agonist in males. J Clin Endocrinol Metab. 76:362-366.
16. Ghai K, Rosenfield RL. 1994 Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge. J Clin Endocrinol Metab. 78:1336-1340.
17. Ghai K, Cara JF, Rosenfield RL. 1995 Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys-a Clinical Research Center study. J Clin Endocrinol Metab. 80:2980-2986.
18. Goodpasture JC, Ghai K, Cara JF, Rosenfield RL. 1993 Potential of gonadotropin-releasing hormone agonists in the diagnosis of pubertal disorders in girls. Clin Obstet Gynecol. 36:773-785.
19. Garibaldi LR, Aceto Jr T, Weber C. 1993 The pattern of gonadotropin and estradiol secretion in exaggerated thelarche. Acta Endocrinol (Copenh). 128:345-350.
20. Ibañez L, Potau N, Virdis R, et al. 1994 Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders. J Clin Endocrinol Metab. 78:30-35.
21. Zamboni G, Antoniazzi F, Tato L. 1995 Use of the gonadotropin-releasing hormone agonist triptorelin in the diagnosis of delayed puberty in boys. J Pediatr. 126:756-758.
22. Bell GL, Karam JH, Rutter WJ. 1981 Polymorphic DNA region adjacent to the 5′ end of the human insulin gene. Proc Natl Acad Sci USA. 78:5759-5763.
23. Van Cauter E. 1981 Quantitative methods for the analysis of circadian and episodic hormone fluctuations. In: Van Cauter E, Copinschi G, eds. Human pituitary hormones: circadian and episodic variations. The Hague: Nyhoff; 1-25.
24. Rosenfield RL, Barnes RB, Ehrmann DA. 1994 Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 79:1686-1692.
25. Kelch RP, Hopwood NJ, Sauder S, Marshall JC. 1985 Evidence for decreased secretion of gonadotropin-releasing hormone in pubertal boys during short-term testosterone treatment. Pediatr Res. 19:112-116.
26. Ito Y, Yano K, Mitamura R, et al. 1992 Sporadic testotoxicosis in Japanese children: Report of 4 cases. Clin Pediatr Endocrinol. 1:95-100.
27. Rosenfeld RG, Reitz RE, King AB, Hintz RL. 1980 Familial precocious puberty associated with isolated elevation of luteinizing hormone. N Erigl J Med. 303:859-862.
28. Yen SSC, Vela P, Rankin J. 1970 Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab. 30:435-442.
29. Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH. 1955 Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA. 92:1322-1326.